The following data are about the Taisho Pharmaceutical Group’s commitment to sustainability.
The following data are about the Taisho Pharmaceutical Group’s commitment to sustainability.
■:Within the scope of SGS Japan Inc.'s verification (third-party verification opinion)
1. Gas used for calculation: Energy-derived CO2
Coefficient used for calculation: Coefficient specified by the Act on Promotion of Global Warming Countermeasures
Range of aggregation: Domestic offices (Taisho Pharmaceutical head office, branches, logistics branches, factories, and research centers)
2. Direct greenhouse gas emissions from the business operator itself
3. Indirect emissions associated with the use of electric power and heat supplied by other companies
■:Within the scope of SGS Japan Inc.'s verification (third-party verification opinion)
1. Gas used for calculation: Energy-derived CO2
Coefficient used for calculation: Coefficient specified by the Act on Promotion of Global Warming Countermeasures
Range of aggregation: Domestic offices (Taisho Pharmaceutical head office, branches, logistics branches, factories, and research centers)
2. Direct greenhouse gas emissions from the business operator itself
3. Indirect emissions associated with the use of electric power and heat supplied by other companies
1. Direct greenhouse gas emissions from the business operator itself
2. Indirect greenhouse gas emissions from the use of electricity, heat, and steam, which are supplied from other companies
3. Indirect emissions other than Scope 1 and Scope 2
4. Gas used for calculation: Energy-derived CO2
Coefficients used for calculation: Referenced from the IDEA v2 LCI database and the Basic Unit of Emissions Database for Calculating Greenhouse Gas Emissions throughout an Organization via its Supply Chain (Ver. 3.2)
1. Direct greenhouse gas emissions from the business operator itself
2. Indirect greenhouse gas emissions from the use of electricity, heat, and steam, which are supplied from other companies
3. Indirect emissions other than Scope 1 and Scope 2
4. Gas used for calculation: Energy-derived CO2
Coefficients used for calculation: Referenced from the IDEA v2 LCI database and the Basic Unit of Emissions Database for Calculating Greenhouse Gas Emissions throughout an Organization via its Supply Chain (Ver. 3.2)
*Coefficients used for calculation: Coefficients specified by the Act on Promotion of Global Warming Countermeasures
*Coefficients used for calculation: Coefficients specified by the Act on Promotion of Global Warming Countermeasures
*The emission factors specified by Saitama Prefecture Ordinance on Promotion of Measures Against Global Warming were used to calculate carbon dioxide emissions.
*The emission factors specified by Saitama Prefecture Ordinance on Promotion of Measures Against Global Warming were used to calculate carbon dioxide emissions.
*Energy use intensity: Amount of energy (kL)/transport amount (10,000 ton-km)
*Energy use intensity: Amount of energy (kL)/transport amount (10,000 ton-km)
*Four materials specified in the Containers and Packaging Recycling Act (calculated up to fiscal 2020 results)
*Four materials specified in the Containers and Packaging Recycling Act (calculated up to fiscal 2020 results)
*1. Data collected from domestic production factories and research centers
*2. Data collected from logistics vehicles (NOx emissions from outsourced transportation)
*3. Data collected from business vehicles
*1. Data collected from domestic production factories and research centers
*2. Data collected from logistics vehicles (NOx emissions from outsourced transportation)
*3. Data collected from business vehicles
* BOD: Biochemical oxygen demand
* BOD: Biochemical oxygen demand
Respondents: Taisho Pharmaceutical Holdings Co., Ltd., Taisho Pharmaceutical Co., Ltd. and Taisho Pharma Co., Ltd.
Respondents: Taisho Pharmaceutical Holdings Co., Ltd., Taisho Pharmaceutical Co., Ltd. and Taisho Pharma Co., Ltd.